Borstkanker Onderzoek Groep Clinical Trials
Sponsors / Borstkanker Onderzoek Groep
According to ClinicalTrials.gov, Borstkanker Onderzoek Groep has served as lead sponsor on 15 registered trials. Across the portfolio, 1 are in recruitment, 6 are active non-recruiting, and 1 have reached completion. 2 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment. Across the portfolio, planned enrollment totals 10,716 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
15
Total Trials
1
Recruiting
6
Other Active
1
Completed
2
Terminated / Withdrawn
10,716
Total Enrollment
Termination reasons: Recruitment100%
Recent Terminations
- Breast Neoplasms"slow accrual rate"
- Metastatic Breast Cancer"due to low accrual rate"
Active Trials (6 total)
- DCIS NANCT02492607
- Breast Cancer PHASE2NCT01898117
- Breast Neoplasms PHASE2NCT03283384
- Breast Neoplasm Female PHASE3NCT03425838
- NCT02271828
- NCT05416164
- Breast Cancer PHASE3NCT01996267